Stratos Wealth Partners, Ltd. Immuno Gen, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$3.94 - $9.7 $1,859 - $4,578	-472 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$8.6 - $11.26 $4,059 - $5,314	472 New	472 $4,000
Q2 2018 Aug 13, 2018	SELL	$9.52 - $12.15 $10,519 - $13,425	-1,105 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$6.7 - $12.95 $3,008 - $5,814	-449 Reduced 28.89%	1,105 $12,000
Q4 2017 Feb 09, 2018	BUY	$5.07 - $7.92 $7,878 - $12,307	1,554	1,554 $10,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.